In this article, Roswitha examines why less than 0.5% of healthcare VC reaches women's health and how funding structure shapes femtech validation rigor and investor trust.

What does it mean to build femtech that works for every woman?

A framework for inclusive validation, algorithmic fairness, and evidence-based reproductive health technology.